<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="90797">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02003053</url>
  </required_header>
  <id_info>
    <org_study_id>IRB00022663</org_study_id>
    <nct_id>NCT02003053</nct_id>
  </id_info>
  <brief_title>A Randomized, Controlled Trial of Inspiratory Muscle Training (IMT)in the ICU and CCU</brief_title>
  <official_title>A Randomized, Controlled Trial of Inspiratory Muscle Training (IMT)in the ICU and CCU</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wake Forest School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wake Forest School of Medicine</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      Inspiratory muscle training (IMT) is an intervention used with success in the outpatient
      setting within the COPD population.  Use of IMT is also theoretically possible during
      mechanical ventilation. This study will determine if the IMT excercise will increase Maximum
      Inspiratory Pressure and will also assess the feseability and safety of the study.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <primary_completion_date type="Anticipated">September 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject)</study_design>
  <primary_outcome>
    <measure>Change in Maximum Inspiratory Pressure at baseline  and before extubation.</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Completion of excercise session</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Time to extubation after start of IMT</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Critically Ill</condition>
  <condition>Respiratory Weakness</condition>
  <arm_group>
    <arm_group_label>IMT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In the IMT group, inspiratory muscle training will start with 30% of MIP, for five minutes twice a day with increments of 10 % (absolute) everyday. Supplemental oxygen will be given as needed. The exercise will be done seven days a week until patient achieves liberation from mechanical ventilation or ICU/CCU discharge.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>In the SHAM group, sham device will be used to train subjects 5 minutes twice a day, seven days a week until patient achieves liberation from mechanical ventilation or ICU/CCU discharge.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Inspiratory Muscle Trainer</intervention_name>
    <arm_group_label>IMT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Mechanically ventilated patients.

          -  Must have passed spontaneuos brething trial screening but failed the trial itself.

          -  Potential subject must be able to perform atleast 5 minutes of spontaneous breathing
             trial.

        Exclusion Criteria:

          -  Known neuromuscular disease

          -  Unstable cardiac ischemia

          -  Tracheostomized patients
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Peter Morris, MD</last_name>
    <phone>3367161210</phone>
    <email>pemorris@wakehealth.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Wake Forest Baptist Medical Center</name>
      <address>
        <city>Winston Salem</city>
        <state>North Carolina</state>
        <zip>27157</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peter Morris, MD</last_name>
      <phone>336-716-1210</phone>
      <email>pemorris@wakehealth.edu</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2014</verification_date>
  <lastchanged_date>June 2, 2014</lastchanged_date>
  <firstreceived_date>November 21, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wake Forest School of Medicine</investigator_affiliation>
    <investigator_full_name>Peter E. Morris</investigator_full_name>
    <investigator_title>Professor and Director Critical Care Trial Group</investigator_title>
  </responsible_party>
  <keyword>Critically ill</keyword>
  <keyword>intubated</keyword>
  <keyword>safety</keyword>
  <keyword>feasibility</keyword>
  <keyword>inspiratory muscle training</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Respiratory Aspiration</mesh_term>
    <mesh_term>Asthenia</mesh_term>
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
